Chao Family Comprehensive Cancer Center University of California, Irvine — Orange, California

Chao Family Comprehensive Cancer Center University of California, Irvine is a clinical research site located in Orange, California, United States 92868.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Chao Family Comprehensive Cancer Center University of California, Irvine has participated in 10 clinical trials with 8 currently active.

Therapeutic areas: Lung Cancer, Driver Mutation, Chronic Myeloid Leukemia.

Sponsors: University of California, Irvine, Incyte Corporation.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Chao Family Comprehensive Cancer Center University of California, Irvine?

Chao Family Comprehensive Cancer Center University of California, Irvine has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Chao Family Comprehensive Cancer Center University of California, Irvine conducted?

Chao Family Comprehensive Cancer Center University of California, Irvine has 10 clinical trials on record, with 8 currently active. Their work covers Lung Cancer, Driver Mutation, Chronic Myeloid Leukemia.

Is Chao Family Comprehensive Cancer Center University of California, Irvine accredited by Crixeo Health?

Yes — Chao Family Comprehensive Cancer Center University of California, Irvine holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Chao Family Comprehensive Cancer Center University of California, Irvine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.